Back to search

Article

Cardiac fibroblast GSK-3α mediates adverse myocardial fibrosis via IL-11 and ERK pathway

2021-02-02

Abstract excerpt

<h4>Background</h4> Heart failure is the leading cause of mortality, morbidity, and healthcare expenditures worldwide. Numerous studies have implicated Glycogen Synthase Kinase-3 (GSK-3) as a promising therapeutic target for cardiovascular diseases. GSK-3 isoforms appear to play overlapping, unique, and even opposing functions in the heart. Recently our group has identified cardiac fibroblast (CF) GSK-3β as a neg...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5b28b072-4ce3-5d60-b23f-ef9bdf1ba59c
DOI
10.1101/2021.02.02.429435
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cardiac fibroblast GSK-3α mediates adverse myocardial fibrosis via IL-11 and ERK pathwayDOI 10.1101/2021.02.02.429435
Select a neighboring publication to make it the new centre.